Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1994 Aug 30;91(18):8710–8714. doi: 10.1073/pnas.91.18.8710

Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains.

G C Smith 1, D G Tew 1, C R Wolf 1
PMCID: PMC44676  PMID: 8078947

Abstract

NADPH-cytochrome P450 oxidoreductase transfers electrons from NADPH to cytochrome P450 and catalyzes the one-electron reduction of many drugs and foreign compounds. This enzyme is a flavoprotein containing the cofactors FMN and FAD, which are essential for its function. We have expressed the putative FMN and FAD/NADPH binding domains of P450 reductase and show that these distinct peptides fold correctly to bind their respective cofactors. The FAD/NADPH domain catalyzed the one-electron reduction of a variety of substrates but did not efficiently reduce cytochrome c or cytochrome P450 (as judged by the oxidation of the CYP1A1 substrate 7-ethoxyresorufin). However, the domains could be combined to provide a functional enzyme active in the reduction of cytochrome c and in transferring electrons to cytochrome P450. Both the reconstitution of the domains and the direct binding of cytochrome c to the FMN domain were ionic-strength dependent. The FMN domain containing the hydrophobic membrane anchor sequence was a potent inhibitor of reconstituted monooxygenase activity. These data strongly support the hypothesis that FMN/FAD-containing proteins have evolved as a fusion of two ancestral genes and provide fundamental insights into how this and structurally related proteins, such as nitric oxide synthase and sulfite reductase, have evolved and function.

Full text

PDF
8714

Images in this article

8711Image
on p.8711
8712Image
on p.8712
8712Image
on p.8712

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Black S. D., French J. S., Williams C. H., Jr, Coon M. J. Role of a hydrophobic polypeptide in the N-terminal region of NADPH-cytochrome P-450 reductase in complex formation with P-450LM. Biochem Biophys Res Commun. 1979 Dec 28;91(4):1528–1535. doi: 10.1016/0006-291x(79)91238-5. [DOI] [PubMed] [Google Scholar]
  2. Bredt D. S., Ferris C. D., Snyder S. H. Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites. J Biol Chem. 1992 Jun 5;267(16):10976–10981. [PubMed] [Google Scholar]
  3. Bredt D. S., Hwang P. M., Glatt C. E., Lowenstein C., Reed R. R., Snyder S. H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 1991 Jun 27;351(6329):714–718. doi: 10.1038/351714a0. [DOI] [PubMed] [Google Scholar]
  4. Burke M. D., Mayer R. T. Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab Dispos. 1974 Nov-Dec;2(6):583–588. [PubMed] [Google Scholar]
  5. Enoch H. G., Strittmatter P. Cytochrome b5 reduction by NADPH-cytochrome P-450 reductase. J Biol Chem. 1979 Sep 25;254(18):8976–8981. [PubMed] [Google Scholar]
  6. Ilan Z., Ilan R., Cinti D. L. Evidence for a new physiological role of hepatic NADPH:ferricytochrome (P-450) oxidoreductase. Direct electron input to the microsomal fatty acid chain elongation system. J Biol Chem. 1981 Oct 10;256(19):10066–10072. [PubMed] [Google Scholar]
  7. Iyanagi T., Makino R., Anan F. K. Studies on the microsomal mixed-function oxidase system: mechanism of action of hepatic NADPH-cytochrome P-450 reductase. Biochemistry. 1981 Mar 31;20(7):1722–1730. doi: 10.1021/bi00510a004. [DOI] [PubMed] [Google Scholar]
  8. Iyanagi T., Mason H. S. Some properties of hepatic reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase. Biochemistry. 1973 Jun 5;12(12):2297–2308. doi: 10.1021/bi00736a018. [DOI] [PubMed] [Google Scholar]
  9. Karplus P. A., Daniels M. J., Herriott J. R. Atomic structure of ferredoxin-NADP+ reductase: prototype for a structurally novel flavoenzyme family. Science. 1991 Jan 4;251(4989):60–66. [PubMed] [Google Scholar]
  10. Keyes S. R., Fracasso P. M., Heimbrook D. C., Rockwell S., Sligar S. G., Sartorelli A. C. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1. Cancer Res. 1984 Dec;44(12 Pt 1):5638–5643. [PubMed] [Google Scholar]
  11. Kurzban G. P., Howarth J., Palmer G., Strobel H. W. NADPH-cytochrome P-450 reductase. Physical properties and redox behavior in the absence of the FAD moiety. J Biol Chem. 1990 Jul 25;265(21):12272–12279. [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. Nadler S. G., Strobel H. W. Identification and characterization of an NADPH-cytochrome P450 reductase derived peptide involved in binding to cytochrome P450. Arch Biochem Biophys. 1991 Nov 1;290(2):277–284. doi: 10.1016/0003-9861(91)90542-q. [DOI] [PubMed] [Google Scholar]
  14. Nisimoto Y. Localization of cytochrome c-binding domain on NADPH-cytochrome P-450 reductase. J Biol Chem. 1986 Oct 25;261(30):14232–14239. [PubMed] [Google Scholar]
  15. Oprian D. D., Coon M. J. Oxidation-reduction states of FMN and FAD in NADPH-cytochrome P-450 reductase during reduction by NADPH. J Biol Chem. 1982 Aug 10;257(15):8935–8944. [PubMed] [Google Scholar]
  16. Ostrowski J., Barber M. J., Rueger D. C., Miller B. E., Siegel L. M., Kredich N. M. Characterization of the flavoprotein moieties of NADPH-sulfite reductase from Salmonella typhimurium and Escherichia coli. Physicochemical and catalytic properties, amino acid sequence deduced from DNA sequence of cysJ, and comparison with NADPH-cytochrome P-450 reductase. J Biol Chem. 1989 Sep 25;264(27):15796–15808. [PubMed] [Google Scholar]
  17. Ponglikitmongkol M., Green S., Chambon P. Genomic organization of the human oestrogen receptor gene. EMBO J. 1988 Nov;7(11):3385–3388. doi: 10.1002/j.1460-2075.1988.tb03211.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Porter T. D., Beck T. W., Kasper C. B. NADPH-cytochrome P-450 oxidoreductase gene organization correlates with structural domains of the protein. Biochemistry. 1990 Oct 23;29(42):9814–9818. doi: 10.1021/bi00494a009. [DOI] [PubMed] [Google Scholar]
  19. Porter T. D., Kasper C. B. Coding nucleotide sequence of rat NADPH-cytochrome P-450 oxidoreductase cDNA and identification of flavin-binding domains. Proc Natl Acad Sci U S A. 1985 Feb;82(4):973–977. doi: 10.1073/pnas.82.4.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Porter T. D., Kasper C. B. NADPH-cytochrome P-450 oxidoreductase: flavin mononucleotide and flavin adenine dinucleotide domains evolved from different flavoproteins. Biochemistry. 1986 Apr 8;25(7):1682–1687. doi: 10.1021/bi00355a036. [DOI] [PubMed] [Google Scholar]
  21. Schacter B. A., Nelson E. B., Marver H. S., Masters B. S. Immunochemical evidence for an association of heme oxygenase with the microsomal electron transport system. J Biol Chem. 1972 Jun 10;247(11):3601–3607. [PubMed] [Google Scholar]
  22. Schmidt H. H., Smith R. M., Nakane M., Murad F. Ca2+/calmodulin-dependent NO synthase type I: a biopteroflavoprotein with Ca2+/calmodulin-independent diaphorase and reductase activities. Biochemistry. 1992 Mar 31;31(12):3243–3249. doi: 10.1021/bi00127a028. [DOI] [PubMed] [Google Scholar]
  23. Sevanian A., Nordenbrand K., Kim E., Ernster L., Hochstein P. Microsomal lipid peroxidation: the role of NADPH--cytochrome P450 reductase and cytochrome P450. Free Radic Biol Med. 1990;8(2):145–152. doi: 10.1016/0891-5849(90)90087-y. [DOI] [PubMed] [Google Scholar]
  24. Shen A. L., Porter T. D., Wilson T. E., Kasper C. B. Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis. J Biol Chem. 1989 May 5;264(13):7584–7589. [PubMed] [Google Scholar]
  25. Shephard E. A., Palmer C. N., Segall H. J., Phillips I. R. Quantification of cytochrome P450 reductase gene expression in human tissues. Arch Biochem Biophys. 1992 Apr;294(1):168–172. doi: 10.1016/0003-9861(92)90152-m. [DOI] [PubMed] [Google Scholar]
  26. Shih M. C., Heinrich P., Goodman H. M. Intron existence predated the divergence of eukaryotes and prokaryotes. Science. 1988 Nov 25;242(4882):1164–1166. doi: 10.1126/science.3055302. [DOI] [PubMed] [Google Scholar]
  27. Vermilion J. L., Ballou D. P., Massey V., Coon M. J. Separate roles for FMN and FAD in catalysis by liver microsomal NADPH-cytochrome P-450 reductase. J Biol Chem. 1981 Jan 10;256(1):266–277. [PubMed] [Google Scholar]
  28. Vermilion J. L., Coon M. J. Identification of the high and low potential flavins of liver microsomal NADPH-cytochrome P-450 reductase. J Biol Chem. 1978 Dec 25;253(24):8812–8819. [PubMed] [Google Scholar]
  29. Vermilion J. L., Coon M. J. Purified liver microsomal NADPH-cytochrome P-450 reductase. Spectral characterization of oxidation-reduction states. J Biol Chem. 1978 Apr 25;253(8):2694–2704. [PubMed] [Google Scholar]
  30. WHITBY L. G. A new method for preparing flavin-adenine dinucleotide. Biochem J. 1953 Jun;54(3):437–442. doi: 10.1042/bj0540437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. WILLIAMS C. H., Jr, KAMIN H. Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver. J Biol Chem. 1962 Feb;237:587–595. [PubMed] [Google Scholar]
  32. Walton M. I., Wolf C. R., Workman P. The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233, WIN 59075) by mouse liver. Biochem Pharmacol. 1992 Jul 22;44(2):251–259. doi: 10.1016/0006-2952(92)90007-6. [DOI] [PubMed] [Google Scholar]
  33. Yasukochi Y., Masters B. S. Some properties of a detergent-solubilized NADPH-cytochrome c(cytochrome P-450) reductase purified by biospecific affinity chromatography. J Biol Chem. 1976 Sep 10;251(17):5337–5344. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES